The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined ...

In the past 12 trading days, the market price of Biocon has appreciated by 20 per cent from a level of ₹349.65 on the BSE on April 24, 2026: Biocon Shares ...

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent ...

Bengaluru-based Biocon said that its Q4 profit stood at ₹198.6. The profit was hit by an exceptional item outgo of ₹80.4 ...

Explore how Biocon successfully reframed its reverse merger narrative into a strategic integration, enhancing market ...

Jain also noted Emcure Pharmaceuticals is sustaining breakout levels. He recounted that the stock's initial IPO-based ...

Candidemia is a bloodstream inflection of serious proportions caused by Candida yeast, and is the fourth-most common ...

In the interview, Mazumdar-Shaw outlined her succession plan as she prepares the four-decade-old group for its next phase of growth. Her to-be successor, Claire Mazumdar, is a 37-year-old biotech ...

Biocon's transformative journey under Kiran Mazumdar-Shaw highlights a significant succession plan and corporate ...

Biocon Biologics has been positioning itself to become a global player in biosimilar drugs. Viatris, a longtime partner to Biocon, is charting a course for its future that does not include biosimilars ...

Latest Announcements - Explore all major announcements by Natural Biocon (india) including board meetings, dividend declarations, AGM/EGM updates, bonus issues, and financial disclosures.

Net profit before exceptional items rose 64 percent year-on-year to Rs.179 crore, indicating improving underlying earnings ...